# Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease

> **NCT04432233** · PHASE4 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Helicobacter Pylori Infection
- Intravenous Drug Usage

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Metronidazole
- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT04432233
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-15
- **Primary completion:** 2021-04-15
- **Final completion:** 2021-06-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04432233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04432233, "Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04432233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*